Reaction Details |
| Report a problem with these data |
Target | Thromboxane-A synthase |
---|
Ligand | BDBM50110444 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEBML_210290 |
---|
IC50 | 465±n/a nM |
---|
Citation | Fujita, M; Seki, T; Inada, H; Shimizu, K; Takahama, A; Sano, T Novel agents combining platelet activating factor (PAF) receptor antagonist with thromboxane synthase inhibitor (TxSI). Bioorg Med Chem Lett12:771-4 (2002) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Thromboxane-A synthase |
---|
Name: | Thromboxane-A synthase |
Synonyms: | CYP5 | CYP5A1 | Cytochrome P450 5A1 | P450 TxA2 | TBXAS1 | THAS_HUMAN | TXA synthase | TXAS | TXS | Thromboxane A2 Synthase | Thromboxane A2 Synthase (P450 TxA2) | Thromboxane Alpha | Thromboxane prostanoid | Thromboxane synthase | Thromboxane-A synthase |
Type: | Enzyme |
Mol. Mass.: | 60524.67 |
Organism: | Homo sapiens (Human) |
Description: | P24557 |
Residue: | 533 |
Sequence: | MEALGFLKLEVNGPMVTVALSVALLALLKWYSTSAFSRLEKLGLRHPKPSPFIGNLTFFR
QGFWESQMELRKLYGPLCGYYLGRRMFIVISEPDMIKQVLVENFSNFTNRMASGLEFKSV
ADSVLFLRDKRWEEVRGALMSAFSPEKLNEMVPLISQACDLLLAHLKRYAESGDAFDIQR
CYCNYTTDVVASVAFGTPVDSWQAPEDPFVKHCKRFFEFCIPRPILVLLLSFPSIMVPLA
RILPNKNRDELNGFFNKLIRNVIALRDQQAAEERRRDFLQMVLDARHSASPMGVQDFDIV
RDVFSSTGCKPNPSRQHQPSPMARPLTVDEIVGQAFIFLIAGYEIITNTLSFATYLLATN
PDCQEKLLREVDVFKEKHMAPEFCSLEEGLPYLDMVIAETLRMYPPAFRFTREAAQDCEV
LGQRIPAGAVLEMAVGALHHDPEHWPSPETFNPERFTAEARQQHRPFTYLPFGAGPRSCL
GVRLGLLEVKLTLLHVLHKFRFQACPETQVPLQLESKSALGPKNGVYIKIVSR
|
|
|
BDBM50110444 |
---|
n/a |
---|
Name | BDBM50110444 |
Synonyms: | CHEMBL351562 | benzyl 5-{[1-{3-[6-(2-chlorophenyl)-1,4-dimethyl-7,8,9,10-tetrahydro-4H-pyrido[4',3':4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-9-ylmethyl]phenyl}-1-(3-pyridyl)-(E)-methylideneamino]-oxy}-pentanoate |
Type | Small organic molecule |
Emp. Form. | C44H42ClN7O3S |
Mol. Mass. | 784.367 |
SMILES | CC1N=C(c2c3CCN(Cc4cccc(c4)C(=N/OCCCCC(=O)OCc4ccccc4)\c4cccnc4)Cc3sc2-n2c(C)nnc12)c1ccccc1Cl |c:2| |
Structure |
|